Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies. (2023)
Attributed to:
Method - Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ecco-jcc/jjac150
PubMed Identifier: 36219564
Publication URI: http://europepmc.org/abstract/MED/36219564
Type: Journal Article/Review
Volume: 17
Parent Publication: Journal of Crohn's & colitis
Issue: 3
ISSN: 1873-9946